Clinical Trials Browser

Phase 1/2 × Pheochromocytoma × lutetium Lu 177 dotatate × Clear all

NCT03923257 2021-06-08

Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents

Phase 1/2 Withdrawn

CNSEndocrineNET

Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors